EUVIMEDEUVIMED entdecken
Crossref

3,6′-Disinapoyl sucrose modulates GALE-mediated metabolic reprogramming to alleviate asthmatic airway inflammation

Haisong Jiang, Ningpo Ding, Zongqi Wang, Fengxiang Shang, Guanghai Yan, Yilan Song

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Haisong Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Yanbian University Medical College, Yanji 133002, PR China; Jilin Key Laboratory for Immune and Targeting Research on C…. Hauptthemen laut MEDLINE: Asthma, UDPglucose 4-Epimerase, Sucrose, Anti-Asthmatic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Jilin Province Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Asthma is a heterogeneous disease characterized by chronic airway inflammation and metabolic dysregulation. Recent studies highlight the role of glycolysis and oxidative phosphorylation (OXPHOS) imbalance in asthma pathogenesis, yet the underlying molecular mechanisms remain unclear. UDP-galactose-4-epimerase (GALE), a key enzyme in galactose metabolism, has not been previously explored in asthma. PURPOSE: This study aimed to identify asthma-associated metabolic genes and investigate the therapeutic potential of 3,6'-Disinapoyl Sucrose (DISS), a natural compound, in modulating GALE-mediated metabolic reprogramming. RESULTS: Weighted Gene Co-Expression Network Analysis (WGCNA) of bronchial epithelial datasets (GSE43696, GSE147878, GSE143303) identified 475 asthma-associated genes enriched in carbohydrate metabolism. Intersection with glycolysis/OXPHOS hallmark genes revealed GALE as a key candidate, validated by machine learning (SVM-RFE, RF, LASSO) and multi-dataset analysis. GALE expression correlated with severe and neutrophilic asthma subtypes. Virtual screening prioritized DISS as a GALE inhibitor (-14.91 kcal/mol), which suppressed glycolysis (reduced ECAR, PFK, PKM, LDHA), restored redox balance (increased SOD/CAT, decreased MDA), and mitigated mitochondrial dysfunction (restored ΔΨm, reduced mtROS) in HDM-stimulated BEAS-2B cells. In vivo, DISS attenuated airway inflammation (reduced IL-4, IL-5, IL-13, IgE), mucus hypersecretion, and pathological remodeling in HDM-induced asthmatic mice. CONCLUSION: GALE-driven metabolic reprogramming is a novel mechanism in asthma progression. DISS alleviates airway inflammation by targeting GALE, normalizing glycolysis, and reducing oxidative stress, offering a promising therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaUDPglucose 4-EpimeraseSucroseAnti-Asthmatic AgentsAnimalsHumansMiceGlycolysisMice, Inbred BALB COxidative PhosphorylationFemaleInflammationDisease Models, AnimalLungMetabolic Reprogramming

Stichwörter der Autor:innen

AsthmaDisinapoyl sucroseGALEGlycolysisMitochondria

Substanzen

UDPglucose 4-EpimeraseSucroseAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, Yanbian University Medical College, Yanji 133002, PR China; Jilin Key Laboratory for Immune and Targeting Research on Common Allergic Diseases, Yanbian University, Yanji 133002, PR China.
  • Jilin Key Laboratory for Immune and Targeting Research on Common Allergic Diseases, Yanbian University, Yanji 133002, PR China; Department of Anatomy, Histology and Embryology, Yanbian University Medical College, Yanji…

Förderung

  • Jilin Province Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, H., Ding, N., Wang, Z., Shang, F., Yan, G., & Song, Y. (2025). 3,6′-Disinapoyl sucrose modulates GALE-mediated metabolic reprogramming to alleviate asthmatic airway inflammation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115463

Vancouver

Jiang H, Ding N, Wang Z, Shang F, Yan G, Song Y. 3,6′-Disinapoyl sucrose modulates GALE-mediated metabolic reprogramming to alleviate asthmatic airway inflammation. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115463

BibTeX
@article{Jiang2025,
  author = {Jiang, Haisong and Ding, Ningpo and Wang, Zongqi and Shang, Fengxiang and Yan, Guanghai and Song, Yilan},
  title = {3,6′-Disinapoyl sucrose modulates GALE-mediated metabolic reprogramming to alleviate asthmatic airway inflammation},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115463}
}
Kostenlos starten →